H.C. Wainwright Reiterates Buy Rating on Caribou Biosciences Inc. (CRBU)

June 16, 2026 6:48 AM

H.C. Wainwright analyst Robert Burns reiterated a Buy rating and $11.00 price target on Caribou Biosciences Inc. (NASDAQ: CRBU).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found